FSD Pharma Cash Conversion Cycle 2011-2026 | HUGE

Annual Cash Conversion Cycle FSD Pharma

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	3.11 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
3.11 K	3.11 K	3.11 K

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	-400	$ 0.89	-	$ 6.54 M	China
ACADIA Pharmaceuticals ACAD	257	$ 22.2	-	$ 3.68 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Edesa Biotech EDSA	97.1	$ 15.9	-	$ 50.8 M	USA
Evogene Ltd. EVGN	-32.5	$ 0.76	-	$ 27.9 M	Israel
Exelixis EXEL	-8.32	$ 44.69	-	$ 12.1 B	USA
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
Galapagos NV GLPG	67.1	$ 27.86	-	$ 2.69 B	Belgium
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Grifols, S.A. GRFS	0.000171	$ 7.91	-	$ 6.83 B	Spain
Harmony Biosciences Holdings HRMY	20.4	$ 31.05	-	$ 1.79 B	USA
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
ImmuCell Corporation ICCC	213	$ 8.44	-	$ 76.2 M	USA
Immuron Limited IMRN	867	$ 0.81	0.3 %	$ 9.47 M	Australia
Incyte Corporation INCY	-54.7	$ 99.1	-	$ 19.3 B	USA
AIkido Pharma AIKI	-1.92	-	1.93 %	$ 17.4 M	USA
InMed Pharmaceuticals INM	184	$ 0.7	-	$ 1.71 M	Canada
INmune Bio INMB	19.9 K	$ 1.33	-	$ 32.9 M	USA
Innoviva INVA	24.6	$ 23.05	-	$ 1.55 B	USA
Jaguar Health JAGX	289	$ 7.88	-	$ 18.4 M	USA
KalVista Pharmaceuticals KALV	-816	$ 26.67	-	$ 1.44 B	Britain
Kamada Ltd. KMDA	163	$ 8.11	-	$ 260 M	Israel
Krystal Biotech KRYS	109	$ 259.95	-	$ 7.52 B	USA
Ligand Pharmaceuticals Incorporated LGND	77.8	$ 224.86	-	$ 4.11 B	USA
Ampio Pharmaceuticals AMPE	-2.85 K	-	-11.43 %	$ 502 K	USA
Liquidia Corporation LQDA	65.5	$ 38.15	-	$ 3.28 B	USA
Aquestive Therapeutics AQST	-172	$ 4.05	-	$ 433 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA